Advertisement
Screener

CHEMBIO DIAGNOSTICS, INC. Net Income (Loss) Available to Common Stockholders, Basic

CHEMBIO DIAGNOSTICS, INC. Net Income (Loss) Available to Common Stockholders, Basic

CHEMBIO DIAGNOSTICS, INC. reported Net Income (Loss) Available to Common Stockholders, Basic of -$2.00 million for the 3-month period ending 2017-12-31, per its 10-K filed 2018-03-08.

Discontinued › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2018-03-08

  • CHEMBIO DIAGNOSTICS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2017-12-31 was -$2.00M.
  • CHEMBIO DIAGNOSTICS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2017-09-30 was -$584.66K.
  • CHEMBIO DIAGNOSTICS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2017-06-30 was -$2.17M.
  • CHEMBIO DIAGNOSTICS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2017-03-31 was -$1.62M.
Period endNet Income (Loss) Available to Common Stockholders, Basic 3 monthNet Income (Loss) Available to Common Stockholders, Basic 6 monthNet Income (Loss) Available to Common Stockholders, Basic 9 monthNet Income (Loss) Available to Common Stockholders, Basic 12 month
2017-12-31-$2.00M
10-K · filed 2018-03-08
-$2.58M
derived: sum of 2 quarters · filed 2018-03-08
-$4.76M
derived: sum of 3 quarters · filed 2018-03-08
-$6.37M
derived: sum of 4 quarters · filed 2018-03-08
2017-09-30-$584.66K
10-K · filed 2018-03-08
-$2.76M
derived: sum of 2 quarters · filed 2018-03-08
-$4.37M
derived: sum of 3 quarters · filed 2018-03-08
-$6.93M
derived: sum of 4 quarters · filed 2018-03-08
2017-06-30-$2.17M
10-K · filed 2018-03-08
-$3.79M
derived: sum of 2 quarters · filed 2018-03-08
-$6.35M
derived: sum of 3 quarters · filed 2018-03-08
-$8.48M
derived: sum of 4 quarters · filed 2018-03-08
2017-03-31-$1.62M
10-K · filed 2018-03-08
-$4.17M
derived: sum of 2 quarters · filed 2018-03-08
-$6.31M
derived: sum of 3 quarters · filed 2018-03-08
-$14.66M
derived: sum of 4 quarters · filed 2018-03-08
2016-12-31-$2.56M
10-K · filed 2018-03-08
-$4.70M
derived: sum of 2 quarters · filed 2018-03-08
-$13.04M
derived: sum of 3 quarters · filed 2018-03-08
-$13.35M
derived: sum of 4 quarters · filed 2018-03-08
2016-09-30-$2.14M
10-K · filed 2018-03-08
-$10.49M
derived: sum of 2 quarters · filed 2018-03-08
-$10.79M
derived: sum of 3 quarters · filed 2018-03-08
-$11.44M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30-$8.35M
10-K · filed 2018-03-08
-$8.65M
derived: sum of 2 quarters · filed 2018-03-08
-$9.30M
derived: sum of 3 quarters · filed 2018-03-08
-$9.74M
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31-$303.59K
10-K · filed 2018-03-08
-$952.57K
derived: sum of 2 quarters · filed 2018-03-08
-$1.39M
derived: sum of 3 quarters · filed 2018-03-08
-$2.05M
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31-$648.98K
10-K · filed 2017-03-07
-$1.09M
derived: sum of 2 quarters · filed 2017-03-07
-$1.75M
derived: sum of 3 quarters · filed 2017-03-07
-$2.40M
derived: sum of 4 quarters · filed 2017-03-07
2015-09-30-$437.16K
10-K · filed 2017-03-07
-$1.10M
derived: sum of 2 quarters · filed 2017-03-07
-$1.75M
derived: sum of 3 quarters · filed 2017-03-07
2015-06-30-$664.09K
10-K · filed 2017-03-07
-$1.31M
derived: sum of 2 quarters · filed 2017-03-07
2015-03-31-$646.82K
10-K · filed 2017-03-07